Michelle Bourne

Leicester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Mepolizumab for COPD with Eosinophilic Phenotype following Hospitalization.

Mepolizumab for COPD with Eosinophilic Phenotype following Hospitalization.

Journal: NEJM evidence

Published: April 30, 2025

Identification of allergens from Aspergillus fumigatus-Potential association with lung damage in asthma.

Identification of allergens from Aspergillus fumigatus-Potential association with lung damage in asthma.

Journal: Allergy

Published: August 28, 2023

The airway fungal microbiome in asthma.

The airway fungal microbiome in asthma.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: November 04, 2019

Mepolizumab does not alter the blood basophil count in severe asthma.

Mepolizumab does not alter the blood basophil count in severe asthma.

Journal: Allergy

Published: May 21, 2019

DP2 antagonism reduces airway smooth muscle mass in asthma by decreasing eosinophilia and myofibroblast recruitment.

DP2 antagonism reduces airway smooth muscle mass in asthma by decreasing eosinophilia and myofibroblast recruitment.

Journal: Science translational medicine

Published: September 21, 2017

The relationship between biomarkers of fungal allergy and lung damage in asthma.

The relationship between biomarkers of fungal allergy and lung damage in asthma.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: May 31, 2016

Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial.

Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial.

Journal: The Lancet. Respiratory medicine

Published: April 15, 2016

Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study).

Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study).

Journal: The Journal of allergy and clinical immunology

Published: May 29, 2013

Isolation of Aspergillus fumigatus from sputum is associated with elevated airborne levels in homes of patients with asthma.

Isolation of Aspergillus fumigatus from sputum is associated with elevated airborne levels in homes of patients with asthma.

Journal: Indoor air

Published: May 14, 2012

Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1.

Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: April 21, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026